Global Pharmaceutical Development Preclinical CRO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 104

Published Date: 03 Jun 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Pharmaceutical Development Preclinical CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Development Preclinical CRO market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Small and Medium Pharmaceutical Company accounting for  % of the Pharmaceutical Development Preclinical CRO global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Bioanalysis and DMPK Studies segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Pharmaceutical Development Preclinical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, and PPD, Inc., etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Pharmaceutical Development Preclinical CRO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Bioanalysis and DMPK Studies
    Toxicology Testing
    Safety Pharmacology
    Others

Market segment by Application, can be divided into
    Small and Medium Pharmaceutical Company
    Large Pharmaceutical Company

Market segment by players, this report covers
    Charles River
    Wuxi AppTec
    Labcorp
    Eurofins Scientific
    PPD, Inc.
    ICON Plc.
    Pharmaron
    Inotiv
    ChemPartner
    JOINN Lab
    EVOTEC
    Medicilon
    Crown Bioscience
    Champion Oncology

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical Development Preclinical CRO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical Development Preclinical CRO, with revenue, gross margin and global market share of Pharmaceutical Development Preclinical CRO from 2019 to 2022.
Chapter 3, the Pharmaceutical Development Preclinical CRO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Development Preclinical CRO market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceutical Development Preclinical CRO research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical Development Preclinical CRO
    1.2 Classification of Pharmaceutical Development Preclinical CRO by Type
        1.2.1 Overview: Global Pharmaceutical Development Preclinical CRO Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type in 2021
        1.2.3 Bioanalysis and DMPK Studies
        1.2.4 Toxicology Testing
        1.2.5 Safety Pharmacology
        1.2.6 Others
    1.3 Global Pharmaceutical Development Preclinical CRO Market by Application
        1.3.1 Overview: Global Pharmaceutical Development Preclinical CRO Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Small and Medium Pharmaceutical Company
        1.3.3 Large Pharmaceutical Company
    1.4 Global Pharmaceutical Development Preclinical CRO Market Size & Forecast
    1.5 Global Pharmaceutical Development Preclinical CRO Market Size and Forecast by Region
        1.5.1 Global Pharmaceutical Development Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Pharmaceutical Development Preclinical CRO Market Size by Region, (2017-2022)
        1.5.3 North America Pharmaceutical Development Preclinical CRO Market Size and Prospect (2017-2028)
        1.5.4 Europe Pharmaceutical Development Preclinical CRO Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size and Prospect (2017-2028)
        1.5.6 South America Pharmaceutical Development Preclinical CRO Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Pharmaceutical Development Preclinical CRO Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pharmaceutical Development Preclinical CRO Market Drivers
        1.6.2 Pharmaceutical Development Preclinical CRO Market Restraints
        1.6.3 Pharmaceutical Development Preclinical CRO Trends Analysis

2 Company Profiles
    2.1 Charles River
        2.1.1 Charles River Details
        2.1.2 Charles River Major Business
        2.1.3 Charles River Pharmaceutical Development Preclinical CRO Product and Solutions
        2.1.4 Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Charles River Recent Developments and Future Plans
    2.2 Wuxi AppTec
        2.2.1 Wuxi AppTec Details
        2.2.2 Wuxi AppTec Major Business
        2.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Solutions
        2.2.4 Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Wuxi AppTec Recent Developments and Future Plans
    2.3 Labcorp
        2.3.1 Labcorp Details
        2.3.2 Labcorp Major Business
        2.3.3 Labcorp Pharmaceutical Development Preclinical CRO Product and Solutions
        2.3.4 Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Labcorp Recent Developments and Future Plans
    2.4 Eurofins Scientific
        2.4.1 Eurofins Scientific Details
        2.4.2 Eurofins Scientific Major Business
        2.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Solutions
        2.4.4 Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Eurofins Scientific Recent Developments and Future Plans
    2.5 PPD, Inc.
        2.5.1 PPD, Inc. Details
        2.5.2 PPD, Inc. Major Business
        2.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Solutions
        2.5.4 PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 PPD, Inc. Recent Developments and Future Plans
    2.6 ICON Plc.
        2.6.1 ICON Plc. Details
        2.6.2 ICON Plc. Major Business
        2.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Product and Solutions
        2.6.4 ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 ICON Plc. Recent Developments and Future Plans
    2.7 Pharmaron
        2.7.1 Pharmaron Details
        2.7.2 Pharmaron Major Business
        2.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Product and Solutions
        2.7.4 Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Pharmaron Recent Developments and Future Plans
    2.8 Inotiv
        2.8.1 Inotiv Details
        2.8.2 Inotiv Major Business
        2.8.3 Inotiv Pharmaceutical Development Preclinical CRO Product and Solutions
        2.8.4 Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Inotiv Recent Developments and Future Plans
    2.9 ChemPartner
        2.9.1 ChemPartner Details
        2.9.2 ChemPartner Major Business
        2.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Product and Solutions
        2.9.4 ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 ChemPartner Recent Developments and Future Plans
    2.10 JOINN Lab
        2.10.1 JOINN Lab Details
        2.10.2 JOINN Lab Major Business
        2.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Product and Solutions
        2.10.4 JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 JOINN Lab Recent Developments and Future Plans
    2.11 EVOTEC
        2.11.1 EVOTEC Details
        2.11.2 EVOTEC Major Business
        2.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Product and Solutions
        2.11.4 EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 EVOTEC Recent Developments and Future Plans
    2.12 Medicilon
        2.12.1 Medicilon Details
        2.12.2 Medicilon Major Business
        2.12.3 Medicilon Pharmaceutical Development Preclinical CRO Product and Solutions
        2.12.4 Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Medicilon Recent Developments and Future Plans
    2.13 Crown Bioscience
        2.13.1 Crown Bioscience Details
        2.13.2 Crown Bioscience Major Business
        2.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Solutions
        2.13.4 Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Crown Bioscience Recent Developments and Future Plans
    2.14 Champion Oncology
        2.14.1 Champion Oncology Details
        2.14.2 Champion Oncology Major Business
        2.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Product and Solutions
        2.14.4 Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Champion Oncology Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Pharmaceutical Development Preclinical CRO Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Pharmaceutical Development Preclinical CRO Players Market Share in 2021
        3.2.2 Top 10 Pharmaceutical Development Preclinical CRO Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Pharmaceutical Development Preclinical CRO Players Head Office, Products and Services Provided
    3.4 Pharmaceutical Development Preclinical CRO Mergers & Acquisitions
    3.5 Pharmaceutical Development Preclinical CRO New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Pharmaceutical Development Preclinical CRO Revenue and Market Share by Type (2017-2022)
    4.2 Global Pharmaceutical Development Preclinical CRO Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2017-2022)
    5.2 Global Pharmaceutical Development Preclinical CRO Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2028)
    6.2 North America Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2028)
    6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country
        6.3.1 North America Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2028)
        6.3.2 United States Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        6.3.3 Canada Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        6.3.4 Mexico Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2028)
    7.2 Europe Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2028)
    7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country
        7.3.1 Europe Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2028)
        7.3.2 Germany Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        7.3.3 France Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        7.3.5 Russia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        7.3.6 Italy Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2028)
    8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2028)
    8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region
        8.3.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Region (2017-2028)
        8.3.2 China Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        8.3.3 Japan Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        8.3.4 South Korea Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        8.3.5 India Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        8.3.7 Australia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2028)
    9.2 South America Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2028)
    9.3 South America Pharmaceutical Development Preclinical CRO Market Size by Country
        9.3.1 South America Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2028)
        9.3.2 Brazil Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        9.3.3 Argentina Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2028)
    10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2028)
    10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country
        10.3.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2028)
        10.3.2 Turkey Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)
        10.3.4 UAE Pharmaceutical Development Preclinical CRO Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pharmaceutical Development Preclinical CRO Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Pharmaceutical Development Preclinical CRO Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Pharmaceutical Development Preclinical CRO Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Pharmaceutical Development Preclinical CRO Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2023-2028)
    Table 6. Charles River Corporate Information, Head Office, and Major Competitors
    Table 7. Charles River Major Business
    Table 8. Charles River Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 9. Charles River Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Wuxi AppTec Corporate Information, Head Office, and Major Competitors
    Table 11. Wuxi AppTec Major Business
    Table 12. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 13. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Labcorp Corporate Information, Head Office, and Major Competitors
    Table 15. Labcorp Major Business
    Table 16. Labcorp Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 17. Labcorp Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
    Table 19. Eurofins Scientific Major Business
    Table 20. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 21. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. PPD, Inc. Corporate Information, Head Office, and Major Competitors
    Table 23. PPD, Inc. Major Business
    Table 24. PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 25. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. ICON Plc. Corporate Information, Head Office, and Major Competitors
    Table 27. ICON Plc. Major Business
    Table 28. ICON Plc. Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 29. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Pharmaron Corporate Information, Head Office, and Major Competitors
    Table 31. Pharmaron Major Business
    Table 32. Pharmaron Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 33. Pharmaron Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Inotiv Corporate Information, Head Office, and Major Competitors
    Table 35. Inotiv Major Business
    Table 36. Inotiv Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 37. Inotiv Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. ChemPartner Corporate Information, Head Office, and Major Competitors
    Table 39. ChemPartner Major Business
    Table 40. ChemPartner Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 41. ChemPartner Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. JOINN Lab Corporate Information, Head Office, and Major Competitors
    Table 43. JOINN Lab Major Business
    Table 44. JOINN Lab Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 45. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. EVOTEC Corporate Information, Head Office, and Major Competitors
    Table 47. EVOTEC Major Business
    Table 48. EVOTEC Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 49. EVOTEC Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Medicilon Corporate Information, Head Office, and Major Competitors
    Table 51. Medicilon Major Business
    Table 52. Medicilon Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 53. Medicilon Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Crown Bioscience Corporate Information, Head Office, and Major Competitors
    Table 55. Crown Bioscience Major Business
    Table 56. Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 57. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Champion Oncology Corporate Information, Head Office, and Major Competitors
    Table 59. Champion Oncology Major Business
    Table 60. Champion Oncology Pharmaceutical Development Preclinical CRO Product and Solutions
    Table 61. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Global Pharmaceutical Development Preclinical CRO Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 63. Global Pharmaceutical Development Preclinical CRO Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 64. Breakdown of Pharmaceutical Development Preclinical CRO by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Pharmaceutical Development Preclinical CRO Players Head Office, Products and Services Provided
    Table 66. Pharmaceutical Development Preclinical CRO Mergers & Acquisitions in the Past Five Years
    Table 67. Pharmaceutical Development Preclinical CRO New Entrants and Expansion Plans
    Table 68. Global Pharmaceutical Development Preclinical CRO Revenue (USD Million) by Type (2017-2022)
    Table 69. Global Pharmaceutical Development Preclinical CRO Revenue Share by Type (2017-2022)
    Table 70. Global Pharmaceutical Development Preclinical CRO Revenue Forecast by Type (2023-2028)
    Table 71. Global Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022)
    Table 72. Global Pharmaceutical Development Preclinical CRO Revenue Forecast by Application (2023-2028)
    Table 73. North America Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
    Table 74. North America Pharmaceutical Development Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
    Table 75. North America Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
    Table 76. North America Pharmaceutical Development Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
    Table 77. North America Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
    Table 78. North America Pharmaceutical Development Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
    Table 79. Europe Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
    Table 80. Europe Pharmaceutical Development Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
    Table 81. Europe Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
    Table 82. Europe Pharmaceutical Development Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
    Table 83. Europe Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
    Table 84. Europe Pharmaceutical Development Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
    Table 87. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
    Table 88. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
    Table 89. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Region (2017-2022) & (USD Million)
    Table 90. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue by Region (2023-2028) & (USD Million)
    Table 91. South America Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
    Table 92. South America Pharmaceutical Development Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
    Table 93. South America Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
    Table 94. South America Pharmaceutical Development Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
    Table 95. South America Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
    Table 96. South America Pharmaceutical Development Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
    Table 99. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
    Table 100. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
    Table 101. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
    Table 102. Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Pharmaceutical Development Preclinical CRO Picture
    Figure 2. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type in 2021
    Figure 3. Bioanalysis and DMPK Studies
    Figure 4. Toxicology Testing
    Figure 5. Safety Pharmacology
    Figure 6. Others
    Figure 7. Pharmaceutical Development Preclinical CRO Revenue Market Share by Application in 2021
    Figure 8. Small and Medium Pharmaceutical Company Picture
    Figure 9. Large Pharmaceutical Company Picture
    Figure 10. Global Pharmaceutical Development Preclinical CRO Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 11. Global Pharmaceutical Development Preclinical CRO Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2017-2028)
    Figure 13. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Region in 2021
    Figure 14. North America Pharmaceutical Development Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Europe Pharmaceutical Development Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. South America Pharmaceutical Development Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Middle East and Africa Pharmaceutical Development Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Pharmaceutical Development Preclinical CRO Market Drivers
    Figure 20. Pharmaceutical Development Preclinical CRO Market Restraints
    Figure 21. Pharmaceutical Development Preclinical CRO Market Trends
    Figure 22. Charles River Recent Developments and Future Plans
    Figure 23. Wuxi AppTec Recent Developments and Future Plans
    Figure 24. Labcorp Recent Developments and Future Plans
    Figure 25. Eurofins Scientific Recent Developments and Future Plans
    Figure 26. PPD, Inc. Recent Developments and Future Plans
    Figure 27. ICON Plc. Recent Developments and Future Plans
    Figure 28. Pharmaron Recent Developments and Future Plans
    Figure 29. Inotiv Recent Developments and Future Plans
    Figure 30. ChemPartner Recent Developments and Future Plans
    Figure 31. JOINN Lab Recent Developments and Future Plans
    Figure 32. EVOTEC Recent Developments and Future Plans
    Figure 33. Medicilon Recent Developments and Future Plans
    Figure 34. Crown Bioscience Recent Developments and Future Plans
    Figure 35. Champion Oncology Recent Developments and Future Plans
    Figure 36. Global Pharmaceutical Development Preclinical CRO Revenue Share by Players in 2021
    Figure 37. Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 38. Global Top 3 Players Pharmaceutical Development Preclinical CRO Revenue Market Share in 2021
    Figure 39. Global Top 10 Players Pharmaceutical Development Preclinical CRO Revenue Market Share in 2021
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 41. Global Pharmaceutical Development Preclinical CRO Revenue Share by Type in 2021
    Figure 42. Global Pharmaceutical Development Preclinical CRO Market Share Forecast by Type (2023-2028)
    Figure 43. Global Pharmaceutical Development Preclinical CRO Revenue Share by Application in 2021
    Figure 44. Global Pharmaceutical Development Preclinical CRO Market Share Forecast by Application (2023-2028)
    Figure 45. North America Pharmaceutical Development Preclinical CRO Sales Market Share by Type (2017-2028)
    Figure 46. North America Pharmaceutical Development Preclinical CRO Sales Market Share by Application (2017-2028)
    Figure 47. North America Pharmaceutical Development Preclinical CRO Revenue Market Share by Country (2017-2028)
    Figure 48. United States Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Canada Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Mexico Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Europe Pharmaceutical Development Preclinical CRO Sales Market Share by Type (2017-2028)
    Figure 52. Europe Pharmaceutical Development Preclinical CRO Sales Market Share by Application (2017-2028)
    Figure 53. Europe Pharmaceutical Development Preclinical CRO Revenue Market Share by Country (2017-2028)
    Figure 54. Germany Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. France Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. United Kingdom Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Russia Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Italy Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Asia-Pacific Pharmaceutical Development Preclinical CRO Sales Market Share by Type (2017-2028)
    Figure 60. Asia-Pacific Pharmaceutical Development Preclinical CRO Sales Market Share by Application (2017-2028)
    Figure 61. Asia-Pacific Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2017-2028)
    Figure 62. China Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Japan Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South Korea Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. India Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Southeast Asia Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Australia Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. South America Pharmaceutical Development Preclinical CRO Sales Market Share by Type (2017-2028)
    Figure 69. South America Pharmaceutical Development Preclinical CRO Sales Market Share by Application (2017-2028)
    Figure 70. South America Pharmaceutical Development Preclinical CRO Revenue Market Share by Country (2017-2028)
    Figure 71. Brazil Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Argentina Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Middle East and Africa Pharmaceutical Development Preclinical CRO Sales Market Share by Type (2017-2028)
    Figure 74. Middle East and Africa Pharmaceutical Development Preclinical CRO Sales Market Share by Application (2017-2028)
    Figure 75. Middle East and Africa Pharmaceutical Development Preclinical CRO Revenue Market Share by Country (2017-2028)
    Figure 76. Turkey Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Saudi Arabia Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. UAE Pharmaceutical Development Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Related Reports

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2023-2029

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2023-2029

date 30 Jan 2023

date Medical Care

The global Pharmaceutical Development Preclinical CRO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Pharmaceutical Development Preclinical CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Pharmaceutical Development Preclinical CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Pharmaceutical Development Preclinical CRO market size was valued at USD 11870 million in 2023 and is forecast to a readjusted size of USD 19910 million by 2030 with a CAGR of 7.7% during review period.

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2024-2030

Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2024-2030

date 17 Feb 2024

date Medical Care

The global Pharmaceutical Development Preclinical CRO market size is expected to reach $ 19910 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

Product Tags

pharmaceutical development preclinical cro

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>